Immunogenicity 12536
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
ERCC4
Transcript ID
uc010bva.3
HLA INFO
C*12:03
TCR INFO
No TCR info found!
Full length protein sequence (372 aa)
MESGQ
1
PARRI
6
AMAPL
11
LEYER
16
QLVLE
21
LLDTD
26
GLVVC
31
ARGLG
36
ADRLL
41
YHFLQ
46
LHCHP
51
ACLVL
56
VLNTQ
61
PAEEE
66
YFINQ
71
LKIEG
76
VEHLP
81
RRVTN
86
EITSN
91
SRYEV
96
YTQGG
101
VIFAT
106
SRILV
111
VDFLT
116
DRIPS
121
DLITG
126
ILVYR
131
AHRII
136
ESCQE
141
AFILR
146
LFRQK
151
NKRGF
156
IKAFT
161
DNAVA
166
FDTGF
171
CHVER
176
VMRNL
181
FVRKL
186
YLWPR
191
FHVAV
196
NSFLE
201
QHKPE
206
VVEIH
211
VSMTP
216
TMLAI
221
QTAIL
226
DILNA
231
CLKEL
236
KCHNP
241
SLEVE
246
DLSLE
251
NAIGK
256
PFDKT
261
IRHYL
266
DPLWH
271
QLGAK
276
TKSLV
281
QDLKI
286
LRTLL
291
QYLSQ
296
YDCVT
301
FLNLL
306
ESLRA
311
TEKAF
316
GQNSG
321
WLFLD
326
SSTSM
331
FINAR
336
ARVYH
341
LPDAK
346
MSKKE
351
KISEK
356
MEIKE
361
GEGIL
366
WG
371
Mutation Information
DNA mutation:
None
Peptide Range:
73 ~ 97
Mut AA position:
85 (13 in Wild Type peptide)
Alignment
Wild Type:
"INQLKIEGVEHLPRRVTNEITSNSR
||||||||||||.||||||||||||
Mutant:
INQLKIEGVEHLSRRVTNEITSNSR"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) ERCC4
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay